Related Experiment Video
Updated: Nov 6, 2025

10:00
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
13.6K
Type I and III interferon responses in SARS-CoV-2 infection
You-Me Kim1,2, Eui-Cheol Shin3,4
1Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea. youmekim@kaist.ac.kr.
Experimental & Molecular Medicine
|May 6, 2021
Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evades crucial immune responses, specifically type I and III interferons (IFNs). Understanding these evasion tactics is key to combating COVID-19 severity.
Area of Science:
- Immunology
- Virology
- Infectious Diseases
Background:
- Type I and III interferons (IFNs) are critical innate immune cytokines for antiviral defense.
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19 and employs strategies to evade host antiviral responses.
Purpose of the Study:
- To review the innate sensing mechanisms of SARS-CoV-2.
- To elucidate the mechanisms by which SARS-CoV-2 evades type I and III IFN responses.
- To discuss the role of IFN responses in COVID-19 pathogenesis.
Main Methods:
- Literature review of innate sensing pathways.
- Analysis of viral evasion strategies against interferon induction and signaling.
- Synthesis of conflicting data on interferon responses in severe COVID-19.
Main Results:
- SARS-CoV-2 utilizes multiple mechanisms to antagonize type I and III IFN responses.
- Contradictory findings exist regarding the status of type I IFN responses in severe COVID-19 patients.
- Delayed and exaggerated type I IFN responses may worsen inflammation and disease severity.
Conclusions:
- SARS-CoV-2 actively subverts essential antiviral interferon pathways.
- The precise role of type I IFNs in COVID-19 severity requires further clarification.
- Aberrant interferon responses contribute to the inflammatory pathology of severe COVID-19.

